Cargando…

Tigecycline pharmacokinetics in critically ill patients on renal replacement therapy: possible warnings and potential perspectives for the research agenda

Detalles Bibliográficos
Autores principales:	Cutuli, Salvatore Lucio, De Pascale, Gennaro, Lisi, Lucia, Carelli, Simone, Navarra, Pierluigi, Antonelli, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560682/ https://www.ncbi.nlm.nih.gov/pubmed/33052543 http://dx.doi.org/10.1186/s13613-020-00759-4

Ejemplares similares

Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections
por: De Pascale, Gennaro, et al.
Publicado: (2020)

Immune Modulation in Critically Ill Septic Patients
por: Cutuli, Salvatore Lucio, et al.
Publicado: (2021)

Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible Acinetobacter baumannii VAP: Clinical, Pharmacokinetic and Microbiome Features
por: De Pascale, Gennaro, et al.
Publicado: (2023)

Vitamin D Status and Potential Therapeutic Options in Critically Ill Patients: A Narrative Review of the Clinical Evidence
por: Cutuli, Salvatore L., et al.
Publicado: (2022)

Population pharmacokinetics of tigecycline in critically ill patients
por: Luo, Xiangru, et al.
Publicado: (2023)

High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria
por: De Pascale, Gennaro, et al.
Publicado: (2014)

The Role of Mannose-Binding Lectin in Severe Sepsis and Septic Shock
por: De Pascale, Gennaro, et al.
Publicado: (2013)

Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic study
por: Broeker, A., et al.
Publicado: (2018)

Noninvasive ventilation and high-flow oxygen therapy for severe community-acquired pneumonia
por: Cutuli, Salvatore Lucio, et al.
Publicado: (2021)

Antimicrobial Exposure in Critically Ill Patients with Sepsis-Associated Multi-Organ Dysfunction Requiring Extracorporeal Organ Support: A Narrative Review
por: Cutuli, Salvatore Lucio, et al.
Publicado: (2023)

High-dose tigecycline use in severe infections
por: De Pascale, G, et al.
Publicado: (2013)

The pharmacokinetics of tigecycline in critically ill adult patients undergoing CVVHD
por: Rypulak, E, et al.
Publicado: (2015)

CO(2) driven endotracheal tube cuff control in critically ill patients: A randomized controlled study
por: De Pascale, Gennaro, et al.
Publicado: (2017)

Renin–angiotensin system dysregulation in critically ill patients with acute respiratory distress syndrome due to COVID-19: a preliminary report
por: Eleuteri, Davide, et al.
Publicado: (2021)

The place of dexmedetomidine light sedation in patients with acute brain injury
por: Carelli, Simone, et al.
Publicado: (2019)

Population Pharmacokinetics of Tigecycline: A Systematic Review
por: Zhou, Can-Can, et al.
Publicado: (2022)

mTOR Kinase: A Possible Pharmacological Target in the Management of Chronic Pain
por: Lisi, Lucia, et al.
Publicado: (2015)

Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin
por: Estes, Kerry S, et al.
Publicado: (2010)

Remdesivir plus Dexamethasone in COVID-19: A cohort study of severe patients requiring high flow oxygen therapy or non-invasive ventilation
por: De Pascale, Gennaro, et al.
Publicado: (2022)

Cefiderocol-containing regimens for the treatment of carbapenem-resistant A. baumannii ventilator-associated pneumonia: a propensity-weighted cohort study
por: Rando, Emanuele, et al.
Publicado: (2023)

Comparative pharmacokinetics of chlortetracycline, tetracycline, minocycline, and tigecycline in broiler chickens
por: Ziółkowski, Hubert, et al.
Publicado: (2020)

Dyspnoea and clinical outcome in critically ill patients receiving noninvasive support for COVID-19 respiratory failure: post hoc analysis of a randomised clinical trial
por: Menga, Luca S., et al.
Publicado: (2021)

The blind spot in high-dose tigecycline pharmacokinetics in critically ill patients: membrane adsorption during continuous extracorporeal treatment
por: Honore, Patrick M, et al.
Publicado: (2015)

Pharmacokinetics of tigecycline in critically ill patients with liver failure defined by maximal liver function capacity test (LiMAx)
por: Alraish, Rawan, et al.
Publicado: (2020)

COVID-19 influences lung microbiota dynamics and favors the emergence of rare infectious diseases: A case report of Hafnia Alvei pneumonia.
por: Cutuli, Salvatore Lucio, et al.
Publicado: (2021)

Use of an innovative cuff pressure control and subglottic secretions drainage system in COVID-19 ARDS patients undergoing pronation
por: Tanzarella, Eloisa Sofia, et al.
Publicado: (2022)

Population Pharmacokinetics of High-Dose Tigecycline in Patients with Sepsis or Septic Shock
por: Borsuk-De Moor, Agnieszka, et al.
Publicado: (2018)

Personalized Respiratory Support in ARDS: A Physiology-to-Bedside Review
por: Cutuli, Salvatore Lucio, et al.
Publicado: (2023)

Effect of pharmacokinetic/pharmacodynamic ratio on tigecycline clinical response and toxicity in critically ill patients with multidrug-resistant Gram-negative infections
por: Ruiz, Jesus, et al.
Publicado: (2020)

Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis
por: De Pascale, Gennaro, et al.
Publicado: (2021)

Tigecycline Dosing Strategies in Critically Ill Liver-Impaired Patients
por: Amann, Lisa F., et al.
Publicado: (2022)

Tigecycline Pharmacokinetic and Pharmacodynamic Profile in Patients with Chronic Obstructive Pulmonary Disease Exacerbation
por: Kipourou, Maria, et al.
Publicado: (2023)

Is ventilated hospital-acquired pneumonia a worse entity than ventilator-associated pneumonia?
por: Vallecoccia, Maria Sole, et al.
Publicado: (2020)

Physiological effects of awake prone position in acute hypoxemic respiratory failure
por: Grieco, Domenico Luca, et al.
Publicado: (2023)

Lice, rodents, and many hopes: a rare disease in a young refugee
por: Cutuli, Salvatore L., et al.
Publicado: (2017)

Double carbapenem as a rescue strategy for the treatment of severe carbapenemase-producing Klebsiella pneumoniae infections: a two-center, matched case–control study
por: De Pascale, Gennaro, et al.
Publicado: (2017)

No dose adjustment of tigecycline is necessary during continuous renal replacement therapy: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020)

Tigecycline as a Second-Line Agent for Legionnaires’ Disease in Severely Ill Patients
por: Slawek, Deepika, et al.
Publicado: (2017)

Clinical characteristics and risk factors of tigecycline-associated hypofibrinogenaemia in critically ill patients
por: Hu, Juan, et al.
Publicado: (2020)

Preliminary experience of tigecycline treatment in critically ill children with ventilator-associated pneumonia
por: Lin, Shupeng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_89en8vkdes1a95i5h2sc5eqi6k